Table 1.
Compound | IC50, μM* | ||
U2OS | U2OS_RH | U2OS_RH + Doxy | |
FG | 15.9 ± 1.2 | 52.8 ± 1.1 | 92.8 ± 1.1 |
FA | 6.77 ± 1.4 | 7.10 ± 1.3 | 7.12 ± 1.3 |
PDS | >50 | >50 | >50 |
Compound concentration inhibiting 50% of cell growth (see SI Appendix, Methods). Cells were exposed to the indicated compound for 24 h, and cell survival was determined after a further 48 h in drug-free medium. Numbers are means ± SD of two biological replicates, each performed in triplicate.